MSH follows WHO-approved treatment protocols, including the use of rapid diagnostic tests (RDTs) and microscopy to improve malaria case management at the facility and community levels. We help strengthen service delivery, referral systems, and supply chains to reach even the most remote and vulnerable populations.
In many countries, inaccurate diagnosis of malaria based on the presence of fever has led to the overuse of antimalarial drugs and increased drug resistance. MSH provides training, mentoring, and supervision to build the capacity of laboratory technicians to ensure appropriate diagnosis and quality control. The growing availability and affordability of RDTs has greatly increased field-based testing for malaria, particularly in Africa. To support this expanded use, MSH works with NMCPs to make RDTs available through the national supply chain and free at public facilities. We also promote the use of RDTs in the private sector through private drug sellers and at the community level through community health workers.
MSH works through integrated health projects, supply chain strengthening activities, and promotion of improved governance and management of programs to support scale up and maintain coverage of high-quality malaria case management services. We work to strengthen referral systems for severe malaria and provide health facilities and community volunteers with advanced medications to treat severe and life-threatening cases.
At the district level, MSH works with facilities, communities, and individuals to build awareness around the importance and availability of treatment. At the national level, MSH works with NMCPs to revise national case management guidelines and training materials and to facilitate dialogue on improving the quality and availability of artemisinin-based combination therapy (ACT) throughout the supply chain.